nodes	percent_of_prediction	percent_of_DWPC	metapath
Cysteamine—MPO—IL23-mediated signaling events—IL18R1—atopic dermatitis	0.0185	0.0431	CbGpPWpGaD
Cysteamine—NPY2R—head—atopic dermatitis	0.0171	0.369	CbGeAlD
Cysteamine—SST—neck—atopic dermatitis	0.0158	0.341	CbGeAlD
Cysteamine—NPY2R—Circadian rythm related genes—RELB—atopic dermatitis	0.00872	0.0203	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CCR3—atopic dermatitis	0.00772	0.018	CbGpPWpGaD
Cysteamine—SST—Mecp2 and Associated Rett Syndrome—BDNF—atopic dermatitis	0.00723	0.0168	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00721	0.0168	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL22—atopic dermatitis	0.00692	0.0161	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CXCR3—atopic dermatitis	0.00675	0.0157	CbGpPWpGaD
Cysteamine—SST—head—atopic dermatitis	0.00666	0.144	CbGeAlD
Cysteamine—SST—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00643	0.015	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL27—atopic dermatitis	0.00616	0.0144	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00577	0.0134	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL17—atopic dermatitis	0.00553	0.0129	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCL27—atopic dermatitis	0.00542	0.0126	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCL27—atopic dermatitis	0.0052	0.0121	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL17A—atopic dermatitis	0.00498	0.0116	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00484	0.0113	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00465	0.0108	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00464	0.0108	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL11—atopic dermatitis	0.00446	0.0104	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00431	0.0101	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL13—atopic dermatitis	0.0043	0.01	CbGpPWpGaD
Cysteamine—NPY2R—Peptide GPCRs—CCR5—atopic dermatitis	0.00423	0.00986	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.00413	0.00964	CbGpPWpGaD
Cysteamine—MPO—skin of body—atopic dermatitis	0.00411	0.0888	CbGeAlD
Cysteamine—SST—SIDS Susceptibility Pathways—TAC1—atopic dermatitis	0.00395	0.00922	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00387	0.00902	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00379	0.00883	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00371	0.00864	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL22—atopic dermatitis	0.00368	0.00859	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR3—atopic dermatitis	0.00363	0.00847	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL22—atopic dermatitis	0.00353	0.00823	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL18—atopic dermatitis	0.0034	0.00792	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00338	0.00787	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00338	0.00787	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00331	0.00772	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL27—atopic dermatitis	0.00328	0.00765	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.00324	0.00755	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.00324	0.00755	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR3—atopic dermatitis	0.0032	0.00745	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.00318	0.0074	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL27—atopic dermatitis	0.00315	0.00734	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00312	0.00727	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—NPS—atopic dermatitis	0.0031	0.00721	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR3—atopic dermatitis	0.00306	0.00714	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00299	0.00697	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL17—atopic dermatitis	0.00295	0.00687	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00284	0.00663	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL17—atopic dermatitis	0.00282	0.00658	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—BDNF—atopic dermatitis	0.00282	0.00656	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00279	0.00651	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL10—atopic dermatitis	0.00269	0.00626	CbGpPWpGaD
Cysteamine—MPO—head—atopic dermatitis	0.00268	0.0579	CbGeAlD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00268	0.00624	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00268	0.00624	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—CCL5—atopic dermatitis	0.00263	0.00612	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—NFKBIA—atopic dermatitis	0.00259	0.00605	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00257	0.00598	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00254	0.00592	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—NGF—atopic dermatitis	0.0025	0.00582	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00249	0.00579	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00244	0.00568	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL11—atopic dermatitis	0.00237	0.00553	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.0023	0.00537	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL11—atopic dermatitis	0.00228	0.00531	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00227	0.00528	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00227	0.00528	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00226	0.00526	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00222	0.00518	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.00221	0.00515	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00217	0.00506	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00217	0.00506	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00217	0.00505	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00213	0.00496	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00208	0.00484	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL4—atopic dermatitis	0.00207	0.00483	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.00199	0.00464	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IFNG—atopic dermatitis	0.00199	0.00464	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00194	0.00453	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR3—atopic dermatitis	0.00194	0.00451	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—CD4—atopic dermatitis	0.00192	0.00448	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL22—atopic dermatitis	0.00189	0.00441	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCL5—atopic dermatitis	0.00186	0.00434	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCL27—atopic dermatitis	0.00186	0.00433	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR3—atopic dermatitis	0.00186	0.00432	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—PPARA—atopic dermatitis	0.00182	0.00425	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL22—atopic dermatitis	0.00181	0.00423	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.0018	0.00419	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCL27—atopic dermatitis	0.00178	0.00415	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL1B—atopic dermatitis	0.00177	0.00414	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL2—atopic dermatitis	0.00177	0.00412	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00175	0.00408	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—NPS—atopic dermatitis	0.00173	0.00402	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—TAC1—atopic dermatitis	0.00173	0.00402	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.00172	0.00401	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCR3—atopic dermatitis	0.00169	0.00394	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL27—atopic dermatitis	0.00169	0.00393	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CCR5—atopic dermatitis	0.00168	0.00391	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—TAC1—atopic dermatitis	0.00165	0.00385	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—NPS—atopic dermatitis	0.00165	0.00385	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCR3—atopic dermatitis	0.00162	0.00378	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL27—atopic dermatitis	0.00162	0.00377	CbGpPWpGaD
Cysteamine—NPY2R—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.00156	0.00363	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00155	0.0036	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IFNG—atopic dermatitis	0.00154	0.00359	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL17—atopic dermatitis	0.00151	0.00352	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.00148	0.00345	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—CXCL8—atopic dermatitis	0.00147	0.00343	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL17—atopic dermatitis	0.00145	0.00338	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL1B—atopic dermatitis	0.00141	0.00329	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00139	0.00325	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL1B—atopic dermatitis	0.00137	0.0032	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL10—atopic dermatitis	0.00137	0.00319	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.00134	0.00311	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CXCL10—atopic dermatitis	0.00131	0.00306	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—TNF—atopic dermatitis	0.00129	0.003	CbGpPWpGaD
Cysteamine—SST—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.00126	0.00293	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IFNG—atopic dermatitis	0.00125	0.00292	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCL11—atopic dermatitis	0.00122	0.00284	CbGpPWpGaD
Cysteamine—NPY2R—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	0.0012	0.0028	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—FCER2—atopic dermatitis	0.0012	0.0028	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCL5—atopic dermatitis	0.00118	0.00274	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCL11—atopic dermatitis	0.00117	0.00272	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—FCER2—atopic dermatitis	0.00115	0.00268	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCL5—atopic dermatitis	0.00113	0.00263	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL22—atopic dermatitis	0.00112	0.0026	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL1B—atopic dermatitis	0.00112	0.0026	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—IL2—atopic dermatitis	0.00111	0.00259	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR3—atopic dermatitis	0.00109	0.00255	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL22—atopic dermatitis	0.00107	0.0025	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CCR5—atopic dermatitis	0.00106	0.00247	CbGpPWpGaD
Cysteamine—SST—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00106	0.00247	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR3—atopic dermatitis	0.00105	0.00244	CbGpPWpGaD
Cysteamine—MPO—IL23-mediated signaling events—IL6—atopic dermatitis	0.00104	0.00242	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—TNF—atopic dermatitis	0.00102	0.00238	CbGpPWpGaD
Cysteamine—NPY2R—GPCR ligand binding—CCR5—atopic dermatitis	0.00102	0.00237	CbGpPWpGaD
Cysteamine—NPY2R—G alpha (i) signalling events—CXCL8—atopic dermatitis	0.00102	0.00237	CbGpPWpGaD
Cysteamine—NPY2R—Circadian rythm related genes—MAPK8—atopic dermatitis	0.00101	0.00236	CbGpPWpGaD
Cysteamine—MPO—C-MYB transcription factor network—CD4—atopic dermatitis	0.000997	0.00232	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—TNF—atopic dermatitis	0.000996	0.00232	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL27—atopic dermatitis	0.000996	0.00232	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000995	0.00232	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CCR3—atopic dermatitis	0.000993	0.00231	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—TAC1—atopic dermatitis	0.000975	0.00227	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—NPS—atopic dermatitis	0.000975	0.00227	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000956	0.00223	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL27—atopic dermatitis	0.000955	0.00222	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR3—atopic dermatitis	0.000952	0.00222	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—TAC1—atopic dermatitis	0.000935	0.00218	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—NPS—atopic dermatitis	0.000935	0.00218	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000917	0.00214	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—IL5—atopic dermatitis	0.000906	0.00211	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CCL17—atopic dermatitis	0.000893	0.00208	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000887	0.00207	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—TAC1—atopic dermatitis	0.000885	0.00206	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—NPS—atopic dermatitis	0.000885	0.00206	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—IL5—atopic dermatitis	0.000869	0.00203	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—CXCR3—atopic dermatitis	0.000868	0.00202	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL17—atopic dermatitis	0.000856	0.002	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—TAC1—atopic dermatitis	0.000849	0.00198	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—NPS—atopic dermatitis	0.000849	0.00198	CbGpPWpGaD
Cysteamine—SST—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000842	0.00196	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CXCR3—atopic dermatitis	0.000832	0.00194	CbGpPWpGaD
Cysteamine—SST—SIDS Susceptibility Pathways—IL6—atopic dermatitis	0.000826	0.00192	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL5—atopic dermatitis	0.000823	0.00192	CbGpPWpGaD
Cysteamine—MPO—Folate Metabolism—TNF—atopic dermatitis	0.000811	0.00189	CbGpPWpGaD
Cysteamine—NPY2R—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.000807	0.00188	CbGpPWpGaD
Cysteamine—MPO—Vitamin B12 Metabolism—IL6—atopic dermatitis	0.000804	0.00187	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—KIF3A—atopic dermatitis	0.000796	0.00185	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL5—atopic dermatitis	0.000789	0.00184	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000773	0.0018	CbGpPWpGaD
Cysteamine—Mood swings—Methylprednisolone—atopic dermatitis	0.000769	0.00147	CcSEcCtD
Cysteamine—Nausea—Dimenhydrinate—atopic dermatitis	0.000768	0.00146	CcSEcCtD
Cysteamine—Nausea—Diphenhydramine—atopic dermatitis	0.000768	0.00146	CcSEcCtD
Cysteamine—Agitation—Tacrolimus—atopic dermatitis	0.000766	0.00146	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—KIF3A—atopic dermatitis	0.000763	0.00178	CbGpPWpGaD
Cysteamine—Lethargy—Betamethasone—atopic dermatitis	0.000753	0.00144	CcSEcCtD
Cysteamine—Lethargy—Dexamethasone—atopic dermatitis	0.000753	0.00144	CcSEcCtD
Cysteamine—Dyspepsia—Mometasone—atopic dermatitis	0.000753	0.00143	CcSEcCtD
Cysteamine—Leukopenia—Tacrolimus—atopic dermatitis	0.000746	0.00142	CcSEcCtD
Cysteamine—Decreased appetite—Mometasone—atopic dermatitis	0.000743	0.00142	CcSEcCtD
Cysteamine—Nausea—Pimecrolimus—atopic dermatitis	0.000743	0.00142	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000741	0.00173	CbGpPWpGaD
Cysteamine—Fatigue—Mometasone—atopic dermatitis	0.000737	0.00141	CcSEcCtD
Cysteamine—Affect lability—Dexamethasone—atopic dermatitis	0.000726	0.00138	CcSEcCtD
Cysteamine—Affect lability—Betamethasone—atopic dermatitis	0.000726	0.00138	CcSEcCtD
Cysteamine—Convulsion—Tacrolimus—atopic dermatitis	0.000722	0.00138	CcSEcCtD
Cysteamine—Hypertension—Tacrolimus—atopic dermatitis	0.00072	0.00137	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL11—atopic dermatitis	0.00072	0.00168	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CMA1—atopic dermatitis	0.00072	0.00168	CbGpPWpGaD
Cysteamine—Asthenia—Loratadine—atopic dermatitis	0.000715	0.00136	CcSEcCtD
Cysteamine—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000708	0.00135	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Tacrolimus—atopic dermatitis	0.000705	0.00134	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL10—atopic dermatitis	0.000702	0.00164	CbGpPWpGaD
Cysteamine—Discomfort—Tacrolimus—atopic dermatitis	0.000701	0.00134	CcSEcCtD
Cysteamine—Gastrointestinal pain—Mometasone—atopic dermatitis	0.000699	0.00133	CcSEcCtD
Cysteamine—Mood swings—Betamethasone—atopic dermatitis	0.000699	0.00133	CcSEcCtD
Cysteamine—Mood swings—Dexamethasone—atopic dermatitis	0.000699	0.00133	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CMA1—atopic dermatitis	0.00069	0.00161	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—CCL11—atopic dermatitis	0.00069	0.00161	CbGpPWpGaD
Cysteamine—Confusional state—Tacrolimus—atopic dermatitis	0.000686	0.00131	CcSEcCtD
Cysteamine—Diarrhoea—Loratadine—atopic dermatitis	0.000682	0.0013	CcSEcCtD
Cysteamine—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.000681	0.0013	CcSEcCtD
Cysteamine—SST—Signaling Pathways—STAT6—atopic dermatitis	0.000677	0.00158	CbGpPWpGaD
Cysteamine—Body temperature increased—Mometasone—atopic dermatitis	0.000676	0.00129	CcSEcCtD
Cysteamine—Abdominal pain—Mometasone—atopic dermatitis	0.000676	0.00129	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL10—atopic dermatitis	0.000673	0.00157	CbGpPWpGaD
Cysteamine—Nervous system disorder—Tacrolimus—atopic dermatitis	0.000667	0.00127	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CCL5—atopic dermatitis	0.000665	0.00155	CbGpPWpGaD
Cysteamine—Skin disorder—Tacrolimus—atopic dermatitis	0.000661	0.00126	CcSEcCtD
Cysteamine—Hypersensitivity—Fluocinolone Acetonide—atopic dermatitis	0.00066	0.00126	CcSEcCtD
Cysteamine—Dizziness—Loratadine—atopic dermatitis	0.000659	0.00126	CcSEcCtD
Cysteamine—Lethargy—Prednisone—atopic dermatitis	0.000656	0.00125	CcSEcCtD
Cysteamine—MPO—Folate Metabolism—IL6—atopic dermatitis	0.000654	0.00152	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—STAT6—atopic dermatitis	0.000649	0.00151	CbGpPWpGaD
Cysteamine—Anorexia—Tacrolimus—atopic dermatitis	0.000649	0.00124	CcSEcCtD
Cysteamine—NPY2R—Circadian rythm related genes—IL6—atopic dermatitis	0.000646	0.00151	CbGpPWpGaD
Cysteamine—MPO—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000644	0.0015	CbGpPWpGaD
Cysteamine—SST—GPCR ligand binding—CXCL8—atopic dermatitis	0.000641	0.00149	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCL5—atopic dermatitis	0.000638	0.00149	CbGpPWpGaD
Cysteamine—Vomiting—Loratadine—atopic dermatitis	0.000633	0.00121	CcSEcCtD
Cysteamine—Affect lability—Prednisone—atopic dermatitis	0.000633	0.00121	CcSEcCtD
Cysteamine—Rash—Loratadine—atopic dermatitis	0.000628	0.0012	CcSEcCtD
Cysteamine—Dermatitis—Loratadine—atopic dermatitis	0.000628	0.0012	CcSEcCtD
Cysteamine—Headache—Loratadine—atopic dermatitis	0.000624	0.00119	CcSEcCtD
Cysteamine—NPY2R—GPCR ligand binding—CXCL8—atopic dermatitis	0.000615	0.00143	CbGpPWpGaD
Cysteamine—Asthenia—Mometasone—atopic dermatitis	0.000613	0.00117	CcSEcCtD
Cysteamine—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.000613	0.00117	CcSEcCtD
Cysteamine—Mood swings—Prednisone—atopic dermatitis	0.000609	0.00116	CcSEcCtD
Cysteamine—Somnolence—Tacrolimus—atopic dermatitis	0.000605	0.00115	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCL5—atopic dermatitis	0.000604	0.00141	CbGpPWpGaD
Cysteamine—SST—GPCR downstream signaling—CCR5—atopic dermatitis	0.000599	0.0014	CbGpPWpGaD
Cysteamine—Dyspepsia—Tacrolimus—atopic dermatitis	0.000599	0.00114	CcSEcCtD
Cysteamine—Hallucination—Hydrocortisone—atopic dermatitis	0.000595	0.00113	CcSEcCtD
Cysteamine—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000592	0.00113	CcSEcCtD
Cysteamine—Nausea—Loratadine—atopic dermatitis	0.000592	0.00113	CcSEcCtD
Cysteamine—Decreased appetite—Tacrolimus—atopic dermatitis	0.000592	0.00113	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.000588	0.00112	CcSEcCtD
Cysteamine—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.000587	0.00112	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR3—atopic dermatitis	0.000587	0.00137	CbGpPWpGaD
Cysteamine—Fatigue—Tacrolimus—atopic dermatitis	0.000587	0.00112	CcSEcCtD
Cysteamine—Diarrhoea—Mometasone—atopic dermatitis	0.000585	0.00112	CcSEcCtD
Cysteamine—Constipation—Tacrolimus—atopic dermatitis	0.000582	0.00111	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CCL5—atopic dermatitis	0.000579	0.00135	CbGpPWpGaD
Cysteamine—NPY2R—GPCR downstream signaling—CCR5—atopic dermatitis	0.000575	0.00134	CbGpPWpGaD
Cysteamine—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.000569	0.00109	CcSEcCtD
Cysteamine—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000565	0.00108	CcSEcCtD
Cysteamine—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000564	0.00108	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR3—atopic dermatitis	0.000563	0.00131	CbGpPWpGaD
Cysteamine—Headache—Fluocinolone Acetonide—atopic dermatitis	0.000561	0.00107	CcSEcCtD
Cysteamine—Feeling abnormal—Tacrolimus—atopic dermatitis	0.000561	0.00107	CcSEcCtD
Cysteamine—Hallucination—Methylprednisolone—atopic dermatitis	0.000559	0.00106	CcSEcCtD
Cysteamine—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.000556	0.00106	CcSEcCtD
Cysteamine—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.000552	0.00105	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CCR5—atopic dermatitis	0.000544	0.00127	CbGpPWpGaD
Cysteamine—Vomiting—Mometasone—atopic dermatitis	0.000544	0.00104	CcSEcCtD
Cysteamine—Urticaria—Tacrolimus—atopic dermatitis	0.000541	0.00103	CcSEcCtD
Cysteamine—Immune system disorder—Hydrocortisone—atopic dermatitis	0.00054	0.00103	CcSEcCtD
Cysteamine—Rash—Mometasone—atopic dermatitis	0.000539	0.00103	CcSEcCtD
Cysteamine—Dermatitis—Mometasone—atopic dermatitis	0.000539	0.00103	CcSEcCtD
Cysteamine—Body temperature increased—Tacrolimus—atopic dermatitis	0.000538	0.00103	CcSEcCtD
Cysteamine—Abdominal pain—Tacrolimus—atopic dermatitis	0.000538	0.00103	CcSEcCtD
Cysteamine—Headache—Mometasone—atopic dermatitis	0.000536	0.00102	CcSEcCtD
Cysteamine—Erythema—Prednisolone—atopic dermatitis	0.000533	0.00102	CcSEcCtD
Cysteamine—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000532	0.00101	CcSEcCtD
Cysteamine—Mental disorder—Hydrocortisone—atopic dermatitis	0.000524	0.000998	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NPS—atopic dermatitis	0.000523	0.00122	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—TAC1—atopic dermatitis	0.000523	0.00122	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—CCR5—atopic dermatitis	0.000522	0.00122	CbGpPWpGaD
Cysteamine—Malnutrition—Hydrocortisone—atopic dermatitis	0.00052	0.000991	CcSEcCtD
Cysteamine—Erythema—Hydrocortisone—atopic dermatitis	0.00052	0.000991	CcSEcCtD
Cysteamine—MPO—Selenium Micronutrient Network—IL6—atopic dermatitis	0.00052	0.00121	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—CXCR3—atopic dermatitis	0.000513	0.0012	CbGpPWpGaD
Cysteamine—Hallucination—Dexamethasone—atopic dermatitis	0.000508	0.000968	CcSEcCtD
Cysteamine—Hallucination—Betamethasone—atopic dermatitis	0.000508	0.000968	CcSEcCtD
Cysteamine—Nausea—Mometasone—atopic dermatitis	0.000508	0.000968	CcSEcCtD
Cysteamine—Immune system disorder—Methylprednisolone—atopic dermatitis	0.000507	0.000967	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—TAC1—atopic dermatitis	0.000501	0.00117	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—NPS—atopic dermatitis	0.000501	0.00117	CbGpPWpGaD
Cysteamine—Hypersensitivity—Tacrolimus—atopic dermatitis	0.000501	0.000956	CcSEcCtD
Cysteamine—Mental disorder—Methylprednisolone—atopic dermatitis	0.000492	0.000937	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCR3—atopic dermatitis	0.000492	0.00115	CbGpPWpGaD
Cysteamine—Erythema—Triamcinolone—atopic dermatitis	0.00049	0.000934	CcSEcCtD
Cysteamine—Malnutrition—Methylprednisolone—atopic dermatitis	0.000489	0.000931	CcSEcCtD
Cysteamine—Erythema—Methylprednisolone—atopic dermatitis	0.000489	0.000931	CcSEcCtD
Cysteamine—Asthenia—Tacrolimus—atopic dermatitis	0.000488	0.000931	CcSEcCtD
Cysteamine—SST—Signaling Pathways—IL5—atopic dermatitis	0.000486	0.00113	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL5—atopic dermatitis	0.000466	0.00109	CbGpPWpGaD
Cysteamine—Diarrhoea—Tacrolimus—atopic dermatitis	0.000466	0.000887	CcSEcCtD
Cysteamine—Convulsion—Prednisolone—atopic dermatitis	0.000461	0.00088	CcSEcCtD
Cysteamine—Hypertension—Prednisolone—atopic dermatitis	0.00046	0.000876	CcSEcCtD
Cysteamine—Convulsion—Hydrocortisone—atopic dermatitis	0.000451	0.000859	CcSEcCtD
Cysteamine—Dizziness—Tacrolimus—atopic dermatitis	0.00045	0.000858	CcSEcCtD
Cysteamine—Hypertension—Hydrocortisone—atopic dermatitis	0.000449	0.000856	CcSEcCtD
Cysteamine—Discomfort—Prednisolone—atopic dermatitis	0.000448	0.000854	CcSEcCtD
Cysteamine—Erythema—Dexamethasone—atopic dermatitis	0.000444	0.000847	CcSEcCtD
Cysteamine—Erythema—Betamethasone—atopic dermatitis	0.000444	0.000847	CcSEcCtD
Cysteamine—Hallucination—Prednisone—atopic dermatitis	0.000442	0.000843	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00044	0.000838	CcSEcCtD
Cysteamine—Discomfort—Hydrocortisone—atopic dermatitis	0.000438	0.000834	CcSEcCtD
Cysteamine—Connective tissue disorder—Prednisone—atopic dermatitis	0.000437	0.000833	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000435	0.000829	CcSEcCtD
Cysteamine—Vomiting—Tacrolimus—atopic dermatitis	0.000433	0.000825	CcSEcCtD
Cysteamine—Rash—Tacrolimus—atopic dermatitis	0.000429	0.000818	CcSEcCtD
Cysteamine—Dermatitis—Tacrolimus—atopic dermatitis	0.000429	0.000817	CcSEcCtD
Cysteamine—Headache—Tacrolimus—atopic dermatitis	0.000426	0.000813	CcSEcCtD
Cysteamine—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000425	0.000809	CcSEcCtD
Cysteamine—Convulsion—Triamcinolone—atopic dermatitis	0.000424	0.000809	CcSEcCtD
Cysteamine—Convulsion—Methylprednisolone—atopic dermatitis	0.000423	0.000807	CcSEcCtD
Cysteamine—Hypertension—Triamcinolone—atopic dermatitis	0.000423	0.000806	CcSEcCtD
Cysteamine—Hypertension—Methylprednisolone—atopic dermatitis	0.000422	0.000804	CcSEcCtD
Cysteamine—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000416	0.000794	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCL10—atopic dermatitis	0.000415	0.000966	CbGpPWpGaD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000413	0.000788	CcSEcCtD
Cysteamine—Skin disorder—Hydrocortisone—atopic dermatitis	0.000412	0.000786	CcSEcCtD
Cysteamine—Discomfort—Triamcinolone—atopic dermatitis	0.000412	0.000785	CcSEcCtD
Cysteamine—Discomfort—Methylprednisolone—atopic dermatitis	0.000411	0.000784	CcSEcCtD
Cysteamine—Anorexia—Hydrocortisone—atopic dermatitis	0.000405	0.000771	CcSEcCtD
Cysteamine—Nausea—Tacrolimus—atopic dermatitis	0.000404	0.00077	CcSEcCtD
Cysteamine—Confusional state—Methylprednisolone—atopic dermatitis	0.000402	0.000767	CcSEcCtD
Cysteamine—Immune system disorder—Prednisone—atopic dermatitis	0.000402	0.000765	CcSEcCtD
Cysteamine—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.0004	0.000762	CcSEcCtD
Cysteamine—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000399	0.00076	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCL10—atopic dermatitis	0.000397	0.000926	CbGpPWpGaD
Cysteamine—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000391	0.000746	CcSEcCtD
Cysteamine—Mental disorder—Prednisone—atopic dermatitis	0.00039	0.000742	CcSEcCtD
Cysteamine—Skin disorder—Methylprednisolone—atopic dermatitis	0.000387	0.000738	CcSEcCtD
Cysteamine—Malnutrition—Prednisone—atopic dermatitis	0.000387	0.000738	CcSEcCtD
Cysteamine—Erythema—Prednisone—atopic dermatitis	0.000387	0.000738	CcSEcCtD
Cysteamine—Convulsion—Dexamethasone—atopic dermatitis	0.000385	0.000734	CcSEcCtD
Cysteamine—Convulsion—Betamethasone—atopic dermatitis	0.000385	0.000734	CcSEcCtD
Cysteamine—Hypertension—Betamethasone—atopic dermatitis	0.000384	0.000731	CcSEcCtD
Cysteamine—Hypertension—Dexamethasone—atopic dermatitis	0.000384	0.000731	CcSEcCtD
Cysteamine—Discomfort—Dexamethasone—atopic dermatitis	0.000374	0.000713	CcSEcCtD
Cysteamine—Discomfort—Betamethasone—atopic dermatitis	0.000374	0.000713	CcSEcCtD
Cysteamine—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000374	0.000712	CcSEcCtD
Cysteamine—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000369	0.000703	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000367	0.000699	CcSEcCtD
Cysteamine—Fatigue—Hydrocortisone—atopic dermatitis	0.000366	0.000698	CcSEcCtD
Cysteamine—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000363	0.000691	CcSEcCtD
Cysteamine—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000363	0.000691	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000362	0.000844	CbGpPWpGaD
Cysteamine—Feeling abnormal—Prednisolone—atopic dermatitis	0.000358	0.000683	CcSEcCtD
Cysteamine—Anaemia—Prednisone—atopic dermatitis	0.000358	0.000682	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCL5—atopic dermatitis	0.000357	0.000832	CbGpPWpGaD
Cysteamine—Nervous system disorder—Betamethasone—atopic dermatitis	0.000356	0.000678	CcSEcCtD
Cysteamine—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000356	0.000678	CcSEcCtD
Cysteamine—Agitation—Prednisone—atopic dermatitis	0.000356	0.000678	CcSEcCtD
Cysteamine—Dyspepsia—Triamcinolone—atopic dermatitis	0.000352	0.000671	CcSEcCtD
Cysteamine—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000351	0.000669	CcSEcCtD
Cysteamine—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.00035	0.000667	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000347	0.00081	CbGpPWpGaD
Cysteamine—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000347	0.000662	CcSEcCtD
Cysteamine—SST—GPCR downstream signaling—IL2—atopic dermatitis	0.000346	0.000807	CbGpPWpGaD
Cysteamine—Anorexia—Dexamethasone—atopic dermatitis	0.000346	0.000659	CcSEcCtD
Cysteamine—Anorexia—Betamethasone—atopic dermatitis	0.000346	0.000659	CcSEcCtD
Cysteamine—Urticaria—Prednisolone—atopic dermatitis	0.000345	0.000658	CcSEcCtD
Cysteamine—Fatigue—Triamcinolone—atopic dermatitis	0.000345	0.000657	CcSEcCtD
Cysteamine—Fatigue—Methylprednisolone—atopic dermatitis	0.000344	0.000655	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCL5—atopic dermatitis	0.000342	0.000797	CbGpPWpGaD
Cysteamine—Urticaria—Hydrocortisone—atopic dermatitis	0.000337	0.000643	CcSEcCtD
Cysteamine—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000336	0.00064	CcSEcCtD
Cysteamine—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000336	0.00064	CcSEcCtD
Cysteamine—Convulsion—Prednisone—atopic dermatitis	0.000335	0.000639	CcSEcCtD
Cysteamine—Hypertension—Prednisone—atopic dermatitis	0.000334	0.000637	CcSEcCtD
Cysteamine—NPY2R—GPCR downstream signaling—IL2—atopic dermatitis	0.000332	0.000774	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—NGF—atopic dermatitis	0.000331	0.00077	CbGpPWpGaD
Cysteamine—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000329	0.000628	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—CXCL8—atopic dermatitis	0.000329	0.000767	CbGpPWpGaD
Cysteamine—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000329	0.000626	CcSEcCtD
Cysteamine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000327	0.000624	CcSEcCtD
Cysteamine—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000326	0.000622	CcSEcCtD
Cysteamine—Discomfort—Prednisone—atopic dermatitis	0.000326	0.000621	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CCR5—atopic dermatitis	0.000322	0.000749	CbGpPWpGaD
Cysteamine—Hypersensitivity—Prednisolone—atopic dermatitis	0.00032	0.00061	CcSEcCtD
Cysteamine—Dyspepsia—Betamethasone—atopic dermatitis	0.000319	0.000609	CcSEcCtD
Cysteamine—Dyspepsia—Dexamethasone—atopic dermatitis	0.000319	0.000609	CcSEcCtD
Cysteamine—Urticaria—Triamcinolone—atopic dermatitis	0.000318	0.000605	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NGF—atopic dermatitis	0.000317	0.000738	CbGpPWpGaD
Cysteamine—Urticaria—Methylprednisolone—atopic dermatitis	0.000317	0.000604	CcSEcCtD
Cysteamine—Body temperature increased—Triamcinolone—atopic dermatitis	0.000316	0.000602	CcSEcCtD
Cysteamine—Anaphylactic shock—Prednisone—atopic dermatitis	0.000316	0.000602	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—CXCL8—atopic dermatitis	0.000315	0.000735	CbGpPWpGaD
Cysteamine—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000315	0.000601	CcSEcCtD
Cysteamine—Decreased appetite—Dexamethasone—atopic dermatitis	0.000315	0.000601	CcSEcCtD
Cysteamine—Decreased appetite—Betamethasone—atopic dermatitis	0.000315	0.000601	CcSEcCtD
Cysteamine—SST—Signaling by GPCR—IL2—atopic dermatitis	0.000314	0.000733	CbGpPWpGaD
Cysteamine—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000313	0.000597	CcSEcCtD
Cysteamine—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000313	0.000597	CcSEcCtD
Cysteamine—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000313	0.000596	CcSEcCtD
Cysteamine—Fatigue—Dexamethasone—atopic dermatitis	0.000313	0.000596	CcSEcCtD
Cysteamine—Fatigue—Betamethasone—atopic dermatitis	0.000313	0.000596	CcSEcCtD
Cysteamine—Nervous system disorder—Prednisone—atopic dermatitis	0.00031	0.00059	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CCR5—atopic dermatitis	0.000308	0.000718	CbGpPWpGaD
Cysteamine—Skin disorder—Prednisone—atopic dermatitis	0.000307	0.000585	CcSEcCtD
Cysteamine—Asthenia—Hydrocortisone—atopic dermatitis	0.000305	0.000581	CcSEcCtD
Cysteamine—NPY2R—Signaling by GPCR—IL2—atopic dermatitis	0.000301	0.000703	CbGpPWpGaD
Cysteamine—Anorexia—Prednisone—atopic dermatitis	0.000301	0.000574	CcSEcCtD
Cysteamine—Feeling abnormal—Betamethasone—atopic dermatitis	0.000299	0.00057	CcSEcCtD
Cysteamine—Feeling abnormal—Dexamethasone—atopic dermatitis	0.000299	0.00057	CcSEcCtD
Cysteamine—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000297	0.000565	CcSEcCtD
Cysteamine—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000297	0.000565	CcSEcCtD
Cysteamine—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000295	0.000561	CcSEcCtD
Cysteamine—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000294	0.00056	CcSEcCtD
Cysteamine—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00029	0.000554	CcSEcCtD
Cysteamine—Urticaria—Betamethasone—atopic dermatitis	0.000288	0.000549	CcSEcCtD
Cysteamine—Urticaria—Dexamethasone—atopic dermatitis	0.000288	0.000549	CcSEcCtD
Cysteamine—Dizziness—Prednisolone—atopic dermatitis	0.000287	0.000548	CcSEcCtD
Cysteamine—Asthenia—Triamcinolone—atopic dermatitis	0.000287	0.000547	CcSEcCtD
Cysteamine—Abdominal pain—Dexamethasone—atopic dermatitis	0.000287	0.000547	CcSEcCtD
Cysteamine—Abdominal pain—Betamethasone—atopic dermatitis	0.000287	0.000547	CcSEcCtD
Cysteamine—Body temperature increased—Betamethasone—atopic dermatitis	0.000287	0.000547	CcSEcCtD
Cysteamine—Body temperature increased—Dexamethasone—atopic dermatitis	0.000287	0.000547	CcSEcCtD
Cysteamine—Asthenia—Methylprednisolone—atopic dermatitis	0.000286	0.000545	CcSEcCtD
Cysteamine—Dizziness—Hydrocortisone—atopic dermatitis	0.000281	0.000535	CcSEcCtD
Cysteamine—Dyspepsia—Prednisone—atopic dermatitis	0.000278	0.00053	CcSEcCtD
Cysteamine—Decreased appetite—Prednisone—atopic dermatitis	0.000275	0.000523	CcSEcCtD
Cysteamine—Rash—Prednisolone—atopic dermatitis	0.000274	0.000522	CcSEcCtD
Cysteamine—Dermatitis—Prednisolone—atopic dermatitis	0.000274	0.000522	CcSEcCtD
Cysteamine—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000273	0.00052	CcSEcCtD
Cysteamine—SST—Signaling Pathways—NFKBIA—atopic dermatitis	0.000273	0.000635	CbGpPWpGaD
Cysteamine—Fatigue—Prednisone—atopic dermatitis	0.000272	0.000519	CcSEcCtD
Cysteamine—Headache—Prednisolone—atopic dermatitis	0.000272	0.000519	CcSEcCtD
Cysteamine—Constipation—Prednisone—atopic dermatitis	0.00027	0.000515	CcSEcCtD
Cysteamine—Vomiting—Hydrocortisone—atopic dermatitis	0.00027	0.000514	CcSEcCtD
Cysteamine—Rash—Hydrocortisone—atopic dermatitis	0.000268	0.00051	CcSEcCtD
Cysteamine—Dermatitis—Hydrocortisone—atopic dermatitis	0.000267	0.00051	CcSEcCtD
Cysteamine—Headache—Hydrocortisone—atopic dermatitis	0.000266	0.000507	CcSEcCtD
Cysteamine—Dizziness—Triamcinolone—atopic dermatitis	0.000264	0.000504	CcSEcCtD
Cysteamine—Dizziness—Methylprednisolone—atopic dermatitis	0.000264	0.000503	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—NFKBIA—atopic dermatitis	0.000261	0.000609	CbGpPWpGaD
Cysteamine—Feeling abnormal—Prednisone—atopic dermatitis	0.00026	0.000496	CcSEcCtD
Cysteamine—Asthenia—Betamethasone—atopic dermatitis	0.00026	0.000496	CcSEcCtD
Cysteamine—Asthenia—Dexamethasone—atopic dermatitis	0.00026	0.000496	CcSEcCtD
Cysteamine—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000258	0.000492	CcSEcCtD
Cysteamine—Nausea—Prednisolone—atopic dermatitis	0.000258	0.000492	CcSEcCtD
Cysteamine—Vomiting—Triamcinolone—atopic dermatitis	0.000254	0.000484	CcSEcCtD
Cysteamine—Vomiting—Methylprednisolone—atopic dermatitis	0.000254	0.000483	CcSEcCtD
Cysteamine—Nausea—Hydrocortisone—atopic dermatitis	0.000252	0.000481	CcSEcCtD
Cysteamine—Rash—Triamcinolone—atopic dermatitis	0.000252	0.00048	CcSEcCtD
Cysteamine—Dermatitis—Triamcinolone—atopic dermatitis	0.000252	0.00048	CcSEcCtD
Cysteamine—Rash—Methylprednisolone—atopic dermatitis	0.000251	0.000479	CcSEcCtD
Cysteamine—Dermatitis—Methylprednisolone—atopic dermatitis	0.000251	0.000479	CcSEcCtD
Cysteamine—Urticaria—Prednisone—atopic dermatitis	0.000251	0.000478	CcSEcCtD
Cysteamine—Headache—Triamcinolone—atopic dermatitis	0.00025	0.000477	CcSEcCtD
Cysteamine—Headache—Methylprednisolone—atopic dermatitis	0.00025	0.000476	CcSEcCtD
Cysteamine—Abdominal pain—Prednisone—atopic dermatitis	0.00025	0.000476	CcSEcCtD
Cysteamine—Body temperature increased—Prednisone—atopic dermatitis	0.00025	0.000476	CcSEcCtD
Cysteamine—Diarrhoea—Dexamethasone—atopic dermatitis	0.000248	0.000473	CcSEcCtD
Cysteamine—Diarrhoea—Betamethasone—atopic dermatitis	0.000248	0.000473	CcSEcCtD
Cysteamine—Dizziness—Dexamethasone—atopic dermatitis	0.00024	0.000457	CcSEcCtD
Cysteamine—Dizziness—Betamethasone—atopic dermatitis	0.00024	0.000457	CcSEcCtD
Cysteamine—Nausea—Triamcinolone—atopic dermatitis	0.000237	0.000453	CcSEcCtD
Cysteamine—Nausea—Methylprednisolone—atopic dermatitis	0.000237	0.000452	CcSEcCtD
Cysteamine—Hypersensitivity—Prednisone—atopic dermatitis	0.000233	0.000444	CcSEcCtD
Cysteamine—Vomiting—Dexamethasone—atopic dermatitis	0.000231	0.00044	CcSEcCtD
Cysteamine—Vomiting—Betamethasone—atopic dermatitis	0.000231	0.00044	CcSEcCtD
Cysteamine—Rash—Betamethasone—atopic dermatitis	0.000229	0.000436	CcSEcCtD
Cysteamine—Rash—Dexamethasone—atopic dermatitis	0.000229	0.000436	CcSEcCtD
Cysteamine—Dermatitis—Betamethasone—atopic dermatitis	0.000228	0.000435	CcSEcCtD
Cysteamine—Dermatitis—Dexamethasone—atopic dermatitis	0.000228	0.000435	CcSEcCtD
Cysteamine—Headache—Betamethasone—atopic dermatitis	0.000227	0.000433	CcSEcCtD
Cysteamine—Headache—Dexamethasone—atopic dermatitis	0.000227	0.000433	CcSEcCtD
Cysteamine—Asthenia—Prednisone—atopic dermatitis	0.000227	0.000432	CcSEcCtD
Cysteamine—Diarrhoea—Prednisone—atopic dermatitis	0.000216	0.000412	CcSEcCtD
Cysteamine—Nausea—Dexamethasone—atopic dermatitis	0.000215	0.000411	CcSEcCtD
Cysteamine—Nausea—Betamethasone—atopic dermatitis	0.000215	0.000411	CcSEcCtD
Cysteamine—Dizziness—Prednisone—atopic dermatitis	0.000209	0.000398	CcSEcCtD
Cysteamine—Vomiting—Prednisone—atopic dermatitis	0.000201	0.000383	CcSEcCtD
Cysteamine—Rash—Prednisone—atopic dermatitis	0.000199	0.00038	CcSEcCtD
Cysteamine—Dermatitis—Prednisone—atopic dermatitis	0.000199	0.000379	CcSEcCtD
Cysteamine—Headache—Prednisone—atopic dermatitis	0.000198	0.000377	CcSEcCtD
Cysteamine—SST—Signaling Pathways—CXCL8—atopic dermatitis	0.000194	0.000453	CbGpPWpGaD
Cysteamine—Nausea—Prednisone—atopic dermatitis	0.000188	0.000358	CcSEcCtD
Cysteamine—NPY2R—Signaling Pathways—CXCL8—atopic dermatitis	0.000186	0.000434	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL2—atopic dermatitis	0.000186	0.000433	CbGpPWpGaD
Cysteamine—SST—Signaling by GPCR—IL6—atopic dermatitis	0.000185	0.000431	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL2—atopic dermatitis	0.000178	0.000415	CbGpPWpGaD
Cysteamine—NPY2R—Signaling by GPCR—IL6—atopic dermatitis	0.000177	0.000413	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—MAPK8—atopic dermatitis	0.000171	0.000398	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—MAPK8—atopic dermatitis	0.000164	0.000382	CbGpPWpGaD
Cysteamine—SST—Signaling Pathways—IL6—atopic dermatitis	0.000109	0.000254	CbGpPWpGaD
Cysteamine—NPY2R—Signaling Pathways—IL6—atopic dermatitis	0.000105	0.000244	CbGpPWpGaD
